Danish Life Science Law Association

Previous events

The first event was held tirsdag den 2. april 2019 kl. 9:00-12:15:

- Kasper Lindgaard, head of the Life Science-unit of the Ministry of Industry, Business and Financial Affairs, who gave a presentation on the work and goals of the unit.
- Henrik Vestergaard, vice-managing director, Lif, who provided a critical stance towards the political focus on the Life Science-field.
- Kristine Peers, General Counsel, EFPIA, who shed light on the challenges which the innovative pharmaceutical industry is facing.

A detailed program can be viewed here


DALILA's second event was held Tuesday 1 October 2019 at 13.00-17.00:

• The Danish Medicines Council represented by Chairman Steen Werner Hansen. He will talk about the tasks and process of the Council.
• Amgros represented by Chief Legal Counsel Maria Marloth Henze. She will talk about procurement and tendering procedures as well as legal issues of special focus.
• Pfizer represented by Health & Value and Communication Director Kjetil Hagen. He will talk about the company's experience with the Danish Medicines Council.

In connection with the event, the general assembly of the association was also held.

A detailed program can be viewed here.


Webinar om COVID 19 og danske life science virksomheder den 27. maj

DALILA afholder webinar den 27. maj kl. 15.00-16.30 med temaet COVID 19 og danske life science virksomheder: Konsekvenser og erfaringer.

Hør bl.a. om
• Erhvervsministeriets life science enhed i COVID 19 krisen – status og erfaringer ved kontorchef Carsten Kjær Joensen, chef for Erhvervsministeriets Life Science enhed
• Case study: Novo Nordisk – erfaringer fra COVID 19 krisen ved advokat Kristine Aachmann Bethe, Director, Pharma Law, Novo Nordisk

Se programmet her

Webinaret er gratis, og der er åbent for tilmelding indtil den 25. maj.

Husk også at vi holder generalforsamling i DALILA den 28. maj 2020 kl. 15.00-16.00. Grundet covid-19-restriktionerne afholdes denne som en videokonference.